Bml-210

CAT: 0400-SIH-348-5MGSize: 5 mgDry Ice: NoHazardous: No
CAT#:0400-SIH-348-5MGSize:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
Description
HDAC inhibitor
CAS Number
537034-17-6
Product Name Alternative
N1- (2-aminophenyl) -N8-phenyloctanediamide
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cell Signaling | Epigenetics and Nuclear Signaling | Cancer
Purity
>98% (TLC), NMR conforms
Weight
0.005
Format
Tan Solid
Solubility
Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol
Molecular Formula
C20H25N3O2
Molecular Weight
339.4
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9. 2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.

Related Products

CatalogName
SIH-435-25MGBml 259
SIH-349-5MGBml-278
SIH-436-50MGBml 277
SIH-436-10MGBml 277
SIH-349-25MGBml-278
SIH-435-5MGBml 259

Alternative Products

CatalogName
MBS131442BML-210, (BML210; BML 210)
MBS3604905-01BML-210
C07493-01BML-210 (CAY10433)
B5968-10BML-210(CAY10433)
A15935-2BML-210 2mg
A15935-25BML-210 25mg
A15935-5BML-210 5mg
A15935-50BML-210 50mg

Popular Products